rs786205076
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_003673.4(TCAP):c.110_110+1delGG(p.Gly37LeufsTer5) variant causes a frameshift, splice donor, splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_003673.4 frameshift, splice_donor, splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCAP | ENST00000309889.3 | c.98_99delGG | p.Arg33LeufsTer5 | frameshift_variant | Exon 1 of 2 | 1 | NM_003673.4 | ENSP00000312624.2 | ||
TCAP | ENST00000578283.1 | c.98_99delGG | p.Arg33LeufsTer5 | frameshift_variant | Exon 1 of 3 | 5 | ENSP00000462787.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cardiovascular phenotype Pathogenic:1
The c.110_110+1delGG pathogenic mutation results from a deletion of 2 nucleotides between positions 110 and 110+1 and involves the canonical splice donor site after coding exon 1 of the TCAP gene. This alteration has been reported in a family with limb girdle muscular dystrophy and cardiac involvement, who was compound heterozygous for an additional alteration in TCAP (Moreira ES et al. Nat Genet. 2000 Feb;24(2):163-6). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition, alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Primary familial hypertrophic cardiomyopathy;C4225408:Hypertrophic cardiomyopathy 25 Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gly37Leufs*5) in the TCAP gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 131 amino acid(s) of the TCAP protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with autosomal recessive limb-girdle muscular dystrophy type 2G (PMID: 10655062). It has also been observed to segregate with disease in related individuals. This variant is also known as c.110_110+1del. ClinVar contains an entry for this variant (Variation ID: 5526). This variant disrupts a region of the TCAP protein in which other variant(s) (p.Gln53*) have been determined to be pathogenic (PMID: 10655062, 23479141, 25298746). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Autosomal recessive limb-girdle muscular dystrophy type 2G;C4225408:Hypertrophic cardiomyopathy 25 Pathogenic:1
- -
Autosomal recessive limb-girdle muscular dystrophy type 2G Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at